IRAK1 and glioblastoma: More than half of the mice bearing U87MG-Lucsh-TRAF6/IRAK1 GBM tumors were alive while only one mouse bearing U87MG-Lucsh-NC GBM tumors was alive at the end of the experiment (7 weeks).